Betta Pharmaceuticals Hits Day High with Strong 4.43% Intraday Surge

Betta Pharmaceuticals Co., Ltd. has experienced a notable uptick in its stock performance, gaining 4.43% on July 1, 2026. The stock reached an intraday high of CNY 69.85, reflecting a strong day of trading activity. Over the past week, Betta Pharmaceuticals has shown impressive growth, with a 15.29% increase, significantly outperforming the China Shanghai Composite, which rose only 0.04% during the same period. In the month leading up to this performance, the stock surged by 32.66%, again surpassing the broader market's 1.35% gain. Year-to-date, Betta Pharmaceuticals has achieved a remarkable 45.53% increase, while the China Shanghai Composite has only managed a 3.62% rise. Despite these short-term gains, the company has faced challenges in long-term growth metrics, with net sales growing at an annual rate of 15.17% and operating profit at 9.21% over the last five years. The stock's current valuation reflects a price-to-book ratio of 2.98 and a return on equity of 5.72%. The dividend yield stands at 0.71%, indicating a high yield relative to its price.